These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 34318740

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Transcatheter closure of ventricular septal defect in aortic valve prolapse and aortic regurgitation.
    Ghosh S, Sridhar A, Solomon N, Sivaprakasham M.
    Indian Heart J; 2018; 70(4):528-532. PubMed ID: 30170648
    [Abstract] [Full Text] [Related]

  • 5. Transcatheter Closure of Perimembranous Ventricular Septal Defect Using the Lifetech Konar-Multi Functional Occluder: Early to Midterm Results of the Indonesian Multicenter Study.
    Kuswiyanto RB, Gunawijaya E, Djer MM, Noormanto, Rahman MA, Murni IK, Sukardi R, Utamayasa A, Ardiansyah R, Nova R, Liliyanti S, Rahayuningsih SE, Anggriawan SL, Rahayuningsih TY, Koentartiwi D, Soewarniaty R, Yantie VK, Nugroho S, Hidayat T, Ontoseno T, Tobing TC, Ali M, Bashari MH, Yosy DS, Arafuri N, Hilmanto D, Yanuarso PB, Advani N, Sastroasmoro S, Putra ST.
    Glob Heart; 2022; 17(1):15. PubMed ID: 35342698
    [Abstract] [Full Text] [Related]

  • 6. Three centers experience with device closure of congenital Gerbode-type perimembranous ventricular septal defects.
    Haddad RN, Boudjemline Y, Combes N, Hadeed K, Karsenty C, Saliba Z.
    J Card Surg; 2022 Sep; 37(9):2714-2724. PubMed ID: 35771212
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Word of caution: Severe aortic valve injury linked to retrograde closure of perimembranous ventricular septal defects.
    Haddad RN, Sawan EB, Saliba Z.
    J Card Surg; 2022 Jun; 37(6):1753-1758. PubMed ID: 35366345
    [Abstract] [Full Text] [Related]

  • 16. Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: immediate and midterm results of an international registry.
    Holzer R, de Giovanni J, Walsh KP, Tometzki A, Goh T, Hakim F, Zabal C, de Lezo JS, Cao QL, Hijazi ZM.
    Catheter Cardiovasc Interv; 2006 Oct; 68(4):620-8. PubMed ID: 16969878
    [Abstract] [Full Text] [Related]

  • 17. Long-term outcomes of percutaneous closure of ventricular septal defects in children using different devices: A single centre experience from Egypt.
    Elmarsafawy H, Hafez M, Alsawah GA, Bakr A, Rakha S.
    BMC Pediatr; 2023 Jul 31; 23(1):381. PubMed ID: 37525132
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Word of caution: silent late device embolisation after perimembranous ventricular septal defect closure in a 6-Kg infant.
    Haddad RN, Saliba Z.
    Cardiol Young; 2024 Feb 31; 34(2):455-458. PubMed ID: 38167420
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.